Dual anti-Ro52 and anti-Ro60 positivity identified as a marker for severe organ involvement and accelerated disease progression in systemic sclerosis
Upadacitinib combination therapy maintained efficacy in systemic lupus erythematosus through 104 weeks
S-ketamine preserved respiratory variability better than midazolam in fibromyalgia patients during sedation
Brain imaging successfully predicted treatment response to TNF inhibitors in rheumatoid arthritis patients
